Active Trials Archives | Page 3 of 3

Amgen 20170542

Research Title: A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration Sponsor: Amgen Principal Investigator: Atul Sharma, MD Description: The purpose of this study is to compare the efficacy and safety of ABP 938 versus Aflibercept (Eylea®) in the treatment of neovascular age-related macular degeneration….

What Our Patients Say

"I would first like to say, that it is a pleasure coming every month to get my eye injections solely based on the staff and my retina specialist! They are always so sweet, well educated, and very welcoming!"

- Hayley

"The staff is kind and very well informed. They walk you through exactly what is happening and give you all your options upfront (including financials). I would 100% recommend and I will be back for an annual checkup!"

- Pardis

"I have a great experience with Georgia Retina staff they make me feel right at home when I walk through the doors."

- Michael

"Dr. Stallman is an excellent physician. The staff in this office give excellent service extrodinar. They are all very kind, professional, and genuinely concerned about your care. Love these folks!"

- Vale

"Very few doctors today display the confidence in their ability that Dr Mukkamala has. And does this without arrogance. He explains a complicated procedure and is sure that you understand when he finishes. I highly recommend him if you need this type of care."

- David

Active Trials

Amgen 20170542

Testimonials

What Our Patients Say